Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study

被引:15
|
作者
Cueto-Manzano, Alfonso M. [1 ]
Espinel-Bermudez, Maria C. [1 ]
Hernandez-Gonzalez, Sandra O. [1 ]
Rojas-Campos, Enrique [1 ]
Nava-Zavala, Arnulfo H. [1 ]
Fuentes-Orozco, Clotilde [1 ]
Balderas-Pena, Luz Ma A. [1 ]
Gonzalez-Ojeda, Alejandro [1 ]
Cortes-Sanabria, Laura [2 ]
Mireles-Ramirez, Mario A. [2 ]
Ramirez-Marquez, Jose J. [3 ]
Martinez-Gutierrez, Porfirio E. [4 ]
Avila-Moran, Maribel [5 ]
De-Dios-Perez, Ramon, I [6 ]
Acosta-Ramirez, Carlos [7 ]
Hernandez-Garcia, Hugo R. [8 ]
机构
[1] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Unidad Invest Biomed 02, Guadalajara, Jalisco, Mexico
[2] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Direcc Invest & Educ, Guadalajara, Jalisco, Mexico
[3] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Div Epidemiol Hosp, Guadalajara, Jalisco, Mexico
[4] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Div Torax & Cardiovasc, Guadalajara, Jalisco, Mexico
[5] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Dept Infect, Guadalajara, Jalisco, Mexico
[6] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Dept Admis Med Continua Urgencias, Guadalajara, Jalisco, Mexico
[7] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Direcc Med, Guadalajara, Jalisco, Mexico
[8] Hosp Especialidades Ctr Med Nacl Occidente IMSS, Direcc Gen, Guadalajara, Jalisco, Mexico
来源
BMJ OPEN | 2021年 / 11卷 / 07期
关键词
COVID-19; infectious diseases; internal medicine; public health; OUTCOMES; SEPSIS;
D O I
10.1136/bmjopen-2021-050321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To describe mortality of in-hospital patients with COVID-19 and compare risk factors between survivors and non-survivors. Design Prospective cohort of adult inpatients. Setting Tertiary healthcare teaching hospital in Guadalajara, Mexico. Participants All patients with confirmed COVID-19 hospitalised from 25 March to 7 September 2020 were included. End of study: 7 November 2020. Primary outcome measures Patient survival analysed by the Kaplan-Meier method and comparison of factors by the log-rank test. Mortality risk factors analysed by multivariate Cox's proportional-hazard model. Results One thousand ten patients included: 386 (38%) died, 618 (61%) alive at discharge and six (0.6%) remained hospitalised. There was predominance of men (63%) and high frequency of overweight-obesity (71%); hypertension (54%); diabetes (40%); and lung (9%), cardiovascular (8%) and kidney diseases (11%); all of them significantly more frequent in non-survivors. Overweight-obesity was not different between groups, but severity of disease (Manchester Triage System and quick Sequential Organ Failure Assessment) was significantly worse in non-survivors, who were also significantly older (65 vs 45 years, respectively) and had haematological, biochemical, coagulation and inflammatory biomarkers more altered than survivors. Mortality predictors were invasive mechanical ventilation (IMV; OR 3.31, p<0.0001), admission to intensive care unit (ICU; OR 2.18, p<0.0001), age (OR 1.02, p<0.0001), Manchester Triage System (urgent OR 1.44, p=0.02; immediate/very urgent OR 2.02, p=0.004), baseline C reactive protein (CRP; OR 1.002, p=0.009) and antecedent of kidney disease (OR 1.58, p=0.04) Conclusions Mortality in hospitalised patients with COVID-19 in this emerging country centre seemed to be higher than in developed countries. Patients displayed a high frequency of risk factors for poor outcome, but the need for IMV, ICU admission, older age, more severe disease at admission, antecedent of kidney disease and higher CRP levels significantly predicted mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mortality risk in a Romanian cohort of patients hospitalised for COVID-19
    Frent, Stefan-Marian
    Bikov, Andras
    Bobu, Emanuel
    Pleava, Roxana
    Serban, Costela
    Marincu, Iosif
    Marc, Monica
    Mihaicuta, Stefan
    Oancea, Cristian
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
    Collard, Didier
    Nurmohamed, Nick S.
    Kaiser, Yannick
    Reeskamp, Laurens F.
    Dormans, Tom
    Moeniralam, Hazra
    Simsek, Suat
    Douma, Renee
    Eerens, Annet
    Reidinga, Auke C.
    Elbers, Paul W. G.
    Beudel, Martijn
    Vogt, Liffert
    Stroes, Erik S. G.
    van den Born, Bert-Jan H.
    BMJ OPEN, 2021, 11 (02):
  • [3] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
    Bramante, Carolyn T.
    Ingraham, Nicholas E.
    Murray, Thomas A.
    Marmor, Schelomo
    Hovertsen, Shane
    Gronski, Jessica
    McNeil, Chace
    Feng, Ruoying
    Guzman, Gabriel
    Abdelwahab, Nermine
    King, Samantha
    Tamariz, Leonardo
    Meehan, Thomas
    Pendleton, Kathryn M.
    Benson, Bradley
    Vojta, Deneen
    Tignanelli, Christopher J.
    LANCET HEALTHY LONGEVITY, 2021, 2 (01): : E34 - E41
  • [4] Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study
    Castro, Marcia C.
    Gurzenda, Susie
    Macario, Eduardo Marques
    Franca, Giovanny Vinicius A.
    BMJ OPEN, 2021, 11 (05):
  • [5] Risk factors for Hyponatremia in COVID-19 hospitalised patients
    Anees, Muhammad
    Raza, Muhammad
    Farooq, Omair
    Mumtaz, Asim
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (01) : 274 - 279
  • [6] Clinical Characteristics and Risk Factors for Mortality in COVID-19 Patients: A Retrospective Cohort Study
    Khajoei, Rahimeh
    Heydarpour, Nabiollah
    Sadeghi, Reza
    Balvardi, Mohadeseh
    Jafari, Hamid
    Shokohian, Sajad
    Rahmani, Farzad
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (05) : LC9 - LC14
  • [7] Analysis of the Risk Factors for Mortality in Adult COVID-19 Patients in Wuhan: A Multicenter Study
    Li, Man
    Cheng, Biao
    Zeng, Wen
    Chen, Sichao
    Tu, Mengqi
    Wu, Meng
    Tong, Wei
    Wang, Shipei
    Huang, Yihui
    Long, Wei
    Zhou, Wei
    Chen, Danyang
    Zhou, Lin
    Wang, Min
    Xu, Haibo
    Deng, Aiping
    Liu, Zeming
    Guo, Liang
    FRONTIERS IN MEDICINE, 2020, 7
  • [8] Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19
    Ahmed, Sibtain
    Ahmed, Zeeshan Ansar
    Rashid, Naveed Haroon
    Mansoor, Maheen
    Siddiqui, Imran
    Jafri, Lena
    MALAYSIAN JOURNAL OF PATHOLOGY, 2021, 43 (03) : 375 - 380
  • [9] Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil
    Chen, Siyu
    Shao, Yong
    LANCET CHILD & ADOLESCENT HEALTH, 2021, 5 (10): : E40 - E40
  • [10] COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
    Guadalupe Rodriguez-Gonzalez, Carmen
    Chamorro-de-Vega, Esther
    Valerio, Maricela
    Angel Amor-Garcia, Miguel
    Tejerina, Francisco
    Sancho-Gonzalez, Milagros
    Narrillos-Moraza, Alvaro
    Gimenez-Manzorro, Alvaro
    Manrique-Rodriguez, Silvia
    Machado, Marina
    Olmedo, Maria
    Escudero-Vilaplana, Vicente
    Villanueva-Bueno, Cristina
    Torroba-Sanz, Beatriz
    Melgarejo-Ortuno, Alejandra
    Vicente-Valor, Juan
    Herranz, Ana
    Bouza, Emilio
    Munoz, Patricia
    Sanjurjo, Maria
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (02)